CN1189201C - Externally applied Chinese medicine for treating osteoarthropathy and its prepn process - Google Patents
Externally applied Chinese medicine for treating osteoarthropathy and its prepn process Download PDFInfo
- Publication number
- CN1189201C CN1189201C CNB021383871A CN02138387A CN1189201C CN 1189201 C CN1189201 C CN 1189201C CN B021383871 A CNB021383871 A CN B021383871A CN 02138387 A CN02138387 A CN 02138387A CN 1189201 C CN1189201 C CN 1189201C
- Authority
- CN
- China
- Prior art keywords
- chinese patent
- present
- patent medicine
- rhizoma
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to an external application Chinese patent drug for curing osteoarthropathy and a preparation technology thereof. The external application Chinese patent drug is prepared from the components of the following weight percentage: 20 to 40% of gardenia, 10 to 25% of safflower, 5 to 20% of dried ginger and 20 to 40% of rhizoma drynariae, and the rest is edible starch. In the preparation technology, the gardenia, the safflower, the dried ginger and the rhizoma drynariae are dried and ground into powder, and the mesh number of the powder is controlled above 80 meshes; after being jointly mixed, the raw material powder and the edible starch are added with spirits, vinegar and distilled water, coordination is carried out so as to preferablely coordinate the raw material traditional Chinese drug powder into a paste shape, and a crude product of the present invention is obtained. The crude product in a paste shape is put in a sealed container for making the crude product stand for at least three days, and the Chinese patent drug of the present invention is obtained. After being used, the Chinese patent drug of the present invention can rapidly relieve inflammation and dropsy edema caused by root compression so as to make the protruded intervertebral cartilages rapidly fold and recover. The Chinese patent drug of the present invention successfully achieves the cure of manifestation and root cause of diseases, can make diseases do not recur, and has no toxic or side effect on human bodies. The Chinese patent drug of the present invention has the advantages of low cost, short cure course, obvious curative effect and broad market prospect.
Description
Technical field
The present invention relates to a kind of external Chinese patent medicine and processing technology thereof for the treatment of osteoarthritis.
Background technology
At present, there is not effect method in disease fashion such as treatment hyperosteogeny, intervertebral disk hernia, traditional methods such as acupuncture-moxibustion commonly used, traction, physical therapy, treatment time is long, and curative effect does not show, and cures the symptoms, not the disease, easily recurrence.From traditional acupuncture, physical therapy, massage, lead the diskectomy that hangs the modern times, artificial intervertebral replacement, intervertebral disc and scrape several different methods such as inhaling art, effect is all not ideal enough.The treatment of Chinese medicine for oral administration (as bony spur tablet, Fengshi maqian tablet etc.) or Western medicine (as Ying Taiqing, ibuprofen etc.) is also arranged in addition, and effect is also undesirable, can only obtain short run effect, and side effect is bigger, and cost is higher.
Summary of the invention
Purpose of the present invention is exactly that it is low to propose a kind of cost in order to address the above problem, and short treating period is evident in efficacy, the external Chinese patent medicine and the processing technology thereof of treatment osteoarthritis without any side effects.
Technical solution of the present invention:
A kind of external Chinese patent medicine for the treatment of osteoarthritis is characterized in that it is made up of Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae and food starch, and the percentage by weight of its each component is:
Fructus Gardeniae 20---40%
Flos Carthami 10---25%
Rhizoma Zingiberis 5---20%
Rhizoma Drynariae 20---40%
The food starch surplus.
A kind of processing technology for the treatment of the external Chinese patent medicine of osteoarthritis is characterized in that:
A. Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae drying are pulverized, the order numerical control is more than 80 orders;
B. adding Chinese liquor, vinegar, distilled water are in harmonious proportion after above-mentioned each raw material powder and food starch together being mixed, and wherein the proportioning between vinegar and the Chinese liquor is:
Vinegar: Chinese liquor=1: 2-10, distilled water consumption make each raw material Chinese medicine powder reconcile into the paste shape after adding vinegar and Chinese liquor, obtain crude product of the present invention;
C. paste shape crude product is placed leave standstill in the sealed container and promptly obtained Chinese patent medicine of the present invention at least in 3 days.
Chinese medicine of the present invention is the external application medication that is developed by plurality of Chinese such as Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae, the Cortex Eucommiae, Radix Salviae Miltiorrhizaes, has the effect of phlegm reduction of blood circulation promoting, dispelling wind and removing obstruction in the collateral, anti-inflammatory analgetic, hard masses softening and resolving and levelling body's immunity according to the rule of treatment of Chinese medicine.After Chinese medicine of the present invention uses, analyze according to observation of curative effect and CT scan review result, can remove rapidly, make outstanding intervertebral disc absorb recovery from illness rapidly because of inflammation, edema that root compression causes, not only successfully reach treating both the principal and secondary aspects of a disease, and be difficult for recurrence, human body is had no toxic and side effects, and cost is low, short treating period, evident in efficacy, remedied the weak point of traditional all multi-methods, have vast market prospect.
The specific embodiment
The external Chinese patent medicine of treatment osteoarthritis of the present invention is made up of Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae and food starch, and the percentage by weight of its each component is:
Fructus Gardeniae 20---40%
Flos Carthami 10---25%
Rhizoma Zingiberis 5---20%
Rhizoma Drynariae 20---40%
The food starch surplus.
In above-mentioned prescription, also can add the Cortex Eucommiae and/or Radix Salviae Miltiorrhizae, addition is respectively the 10-20% and the 15-25% of above-mentioned raw materials total amount.
The also available Cortex Moutan of Fructus Gardeniae in the Chinese medicine of the present invention, Radix Sophorae Flavescentis and/or Rhizoma Polygoni Cuspidati replace, and its consumption is identical, and they can use separately, and also hybrid combining is used arbitrarily.
The also available Radix Angelicae Sinensis of Flos Carthami in the Chinese medicine of the present invention and/or the Radix Angelicae Dahuricae replace, and its consumption is identical, and they can use separately, and also hybrid combining is used arbitrarily.
Also available fresh ginger of Rhizoma Zingiberis in the Chinese medicine of the present invention and/or Rhizoma Alpiniae Officinarum replace, and its consumption is identical, and they can use separately, and also hybrid combining is used arbitrarily.
The also available natural ketone of Rhizoma Drynariae, Radix Morindae Officinalis and/or Radix Clematidis replace, and its consumption is identical, and they can use separately, and also hybrid combining is used arbitrarily.
The processing technology of external Chinese patent medicine that the present invention treats osteoarthritis is as follows:
1, Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae drying are pulverized, the order numerical control is (fineness is thin more good more) more than 80 orders.
2, above-mentioned each raw material powder and food starch are together mixed the back and add Chinese liquor, vinegar, distilled water and be in harmonious proportion, wherein the proportioning between vinegar and the Chinese liquor is:
Vinegar: Chinese liquor=1: 2-10, the distilled water consumption makes each raw material Chinese medicine powder reconcile into the paste shape behind vinegar and the Chinese liquor to be advisable, to obtain crude product of the present invention to add.
3, paste shape crude product is placed leave standstill in the sealed container and promptly obtained Chinese patent medicine of the present invention at least in 3 days.
During use, only need need to take out an amount of paste shape Chinese patent medicine according to conditions of patients and be applied on the medical proof fabric, stick on patient's symptom place then and get final product, changed one time medicine in common 1-3 days, can take effect for 2-3 time, serious symptom person can cure for about 10 times.
The external Chinese patent medicine of treatment osteoarthritis of the present invention adopts multiple pure Chinese medicine formulated, and its method is their common levigation ends to be added the wine vinegar modulation form.Principle and clinical verification according to Chinese medicine confirm, external Chinese patent medicine of the present invention has blood circulation promoting and blood stasis dispelling, dispelling wind and removing obstruction in the collateral, anti-inflammatory analgetic, hard masses softening and resolving, activation osteocyte, promotes the function of bone metabolism, enhancing bone density, osteoporosis is taken a turn for the better, the perverse softening absorption of bone, hydrarthrosis disappears, and pain disappears; Can improve the metabolism of disc tissue, outstanding disc tissue is also received to original position, eliminate nerve root inflammation edema, remove the root compression symptom, as numb limbs and tense tendons pain, the dyskinesia, symptoms such as amyotrophy can rehabilitate rapidly, because the penetration of invigorating blood circulation of Chinese patent medicine of the present invention is extremely strong, also there is specially good effect the efficacy of a drug darker sick position of body of can going directly so be used for the treatment of diseases such as acute and chronic tracheitis, coronary heart disease, menoxenia.
Embodiment (is example to produce 100 kilograms of Chinese patent medicines):
Get 30 kilograms in Fructus Gardeniae powder, 10 kilograms of Flos Carthami powder, 10 kilograms of ginger powders, Rhizoma Drynariae powder and together put into stirred vessel for 30 kilograms, (also can add 10 kilograms Radix Salviae Miltiorrhizae powder and 15 kilograms Cortex Eucommiae powder this moment), tablet vinegar and 3 kilograms of high spirits of adding 1 kilogram then, and constantly constantly adding distilled water under the condition of stirring, till each raw material powder stirring in the stirred vessel is reconciled into the paste shape, take out then and put into sealed container, leave standstill more than three days or three days, promptly obtain Chinese patent medicine of the present invention.
The foregoing description is a non-limiting example, the external Chinese patent medicine that all can be made into treatment osteoarthritis of the present invention according to the proportioning and the method for aforementioned each material composition.
The external Chinese patent medicine of treatment osteoarthritis of the present invention has the good clinical effect, it cures mainly surplus the diseases 2000 such as rheumatism and rheumatoid arthritis, hyperosteogeny, intervertebral disc prolapse, ankylosing spondylitis, aseptic necrosis of femoral head, traumatic injury, fracture person-time, the effect uniqueness.Once the efficacy analysis of 61 routine prolapse of lumbar intervertebral disc is added up its total effective rate and reach 98%, cure rate reaches 91.4%, and diseases such as acute and chronic tracheitis, asthma, menoxenia, adnexitis, cyclomastopathy, scabies carbuncle, the tuberculosis of cervical lymph nodes, prostatic hyperplasia are also had specially good effect.External Chinese patent medicine of the present invention and other medicines treatment synopsis are as follows:
| Nomenclature of drug | Curative effect | The course of treatment | Side effect | Medication | Expense | Effective cure rate | |||||||
| Hurry up | Slowly | Do not have | Short | Long | Do not have | Have | Easy | Owe easy | Low | High | High | Low | |
| Chinese patent medicine of the present invention | √ | √ | √ | √ | √ | √ | |||||||
| Bony spur tablet, JINGFUKANG English are too blue or green, maqian tablet | √ | √ | √ | √ | √ | √ | √ | ||||||
| The penicillin antitussive | √ | √ | √ | √ | √ | √ | √ | ||||||
| The erythromycin ointment YUSHIZHI RUANGAO | √ | √ | √ | √ | √ | √ | |||||||
| The spirit of Herba Leonuri paste Chinese angelica extract tablet woman light | √ | √ | √ | √ | √ | √ | √ | ||||||
Claims (7)
1, a kind of external Chinese patent medicine for the treatment of osteoarthritis is characterized in that it is made up of Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis and Rhizoma Drynariae basically, and the percentage by weight of its each component is:
Fructus Gardeniae 20---40%
Flos Carthami 10---25%
Rhizoma Zingiberis 5---20%
Rhizoma Drynariae 20---40%.
2, a kind of external Chinese patent medicine for the treatment of osteoarthritis, it is characterized in that it is made up of the Rhizoma Drynariae of the Rhizoma Zingiberis of the Flos Carthami of the Fructus Gardeniae of 20-40%, 10-25%, 5-20%, 20-40% and the Cortex Eucommiae and/or Radix Salviae Miltiorrhizae basically, wherein the above-mentioned respectively four kinds of components of the Cortex Eucommiae and Radix Salviae Miltiorrhizae addition add the 10-20% and the 15-25% of total amount.
3, by the external Chinese patent medicine of the described treatment osteoarthritis of claim 1, it is characterized in that described Fructus Gardeniae replaces with Cortex Moutan, Radix Sophorae Flavescentis and/or Rhizoma Polygoni Cuspidati, its consumption is identical, they or use separately, or hybrid combining is used arbitrarily.
4, by the external Chinese patent medicine of the described treatment osteoarthritis of claim 1, it is characterized in that described Flos Carthami replaces with the Radix Angelicae Sinensis and/or the Radix Angelicae Dahuricae, its consumption is identical, they or use separately, or hybrid combining is used arbitrarily.
5, by the external Chinese patent medicine of the described treatment osteoarthritis of claim 1, it is characterized in that described Rhizoma Zingiberis replaces with fresh ginger and/or Rhizoma Alpiniae Officinarum, its consumption is identical, they or use separately, or hybrid combining is used arbitrarily.
6, by the external Chinese patent medicine of the described treatment osteoarthritis of claim 1, it is characterized in that described Rhizoma Drynariae replaces with nature ketone, Radix Morindae Officinalis and/or Radix Clematidis, its consumption is identical, they or use separately, or hybrid combining is used arbitrarily.
7, a kind of processing technology of Chinese patent medicine according to claim 1 is characterized in that:
A. Fructus Gardeniae, Flos Carthami, Rhizoma Zingiberis, Rhizoma Drynariae drying are pulverized, the order numerical control is more than 80 orders;
B. adding Chinese liquor, vinegar, distilled water are in harmonious proportion after above-mentioned each raw material powder and food starch together being mixed, and wherein the proportioning between vinegar and the Chinese liquor is:
Vinegar: Chinese liquor=1: 2-10, distilled water consumption make each raw material Chinese medicine powder reconcile into the paste shape after adding vinegar and Chinese liquor, obtain crude product;
C. paste shape crude product is placed leave standstill in the sealed container and promptly obtained Chinese patent medicine at least in 3 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021383871A CN1189201C (en) | 2002-10-08 | 2002-10-08 | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021383871A CN1189201C (en) | 2002-10-08 | 2002-10-08 | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1403139A CN1403139A (en) | 2003-03-19 |
| CN1189201C true CN1189201C (en) | 2005-02-16 |
Family
ID=4749452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021383871A Expired - Fee Related CN1189201C (en) | 2002-10-08 | 2002-10-08 | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1189201C (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102579635B (en) * | 2012-02-23 | 2014-04-30 | 王立新 | Topical Chinese medicinal composition for treating prolapse of lumbar intervertebral disc |
| CN102579634B (en) * | 2012-02-23 | 2014-10-08 | 熊桂华 | Externally applied traditional Chinese medicine composition for treating knee osteoarthritis (OA) |
| CN104740568B (en) * | 2015-03-31 | 2018-09-21 | 新疆医科大学 | A kind of external application Chinese medicine and its preparation process for treating knee osteoarthritis |
| CN104815018A (en) * | 2015-05-27 | 2015-08-05 | 苗怡文 | Traditional Chinese medicine for treating rheumatoid arthritis and preparation method of traditional Chinese medicine |
| CN104970359A (en) * | 2015-06-19 | 2015-10-14 | 卢雨萍 | Rheumatism curing dietary therapy formula and preparation method thereof |
| CN105194367A (en) * | 2015-09-18 | 2015-12-30 | 马鞍山德宏堂生物科技有限公司 | External-use traditional Chinese medicine for treating bone fractures |
| CN106110268A (en) * | 2016-08-03 | 2016-11-16 | 刘鹏 | A kind of Chinese medicine composition treating traumatic injury and using method |
| CN107496628A (en) * | 2017-08-17 | 2017-12-22 | 河南中医药大学 | Treat traumatic injury, Traditional Chinese medicine gel emplastrum that extravasated blood swells and ache and preparation method thereof |
| CN109010763A (en) * | 2018-09-03 | 2018-12-18 | 刘亚莉 | A kind of plaster for treating bone joint pain |
| CN110038063A (en) * | 2019-06-04 | 2019-07-23 | 吕峰展 | A kind of drug and preparation method thereof for treating ankylosing spondylitis |
| CN111450216A (en) * | 2020-04-29 | 2020-07-28 | 罗中涛 | Special smearing preparation for treating rheumatic bone diseases |
-
2002
- 2002-10-08 CN CNB021383871A patent/CN1189201C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1403139A (en) | 2003-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1189201C (en) | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process | |
| CN1742979A (en) | Chinese medicine for treating proliferation of mammary gland | |
| CN1422646A (en) | Chinese medicinal preparation for treating osteoproliferation and various rheumatalgia | |
| CN1290550C (en) | Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof | |
| CN1124156C (en) | Chinese-medicinal pills for treating rheumatism and preparing process thereof | |
| CN1931277A (en) | Osteoarthrosis treating Chinese medicine composition and its prepn process | |
| CN1883575A (en) | Chinese medicine for treating hyperosteogeny | |
| CN1406594A (en) | Oral Chinese medicine for osteoarthritis | |
| CN1225254C (en) | Medicinal composition, its preparation process and use in treating psoriasis | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1270053A (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN103301215B (en) | Pharmaceutical composition for treating bone disease as well as preparation method and use thereof | |
| CN105688059A (en) | Traditional Chinese medicine preparation with folium artemisiae argyi for treating osteoproliferation through external application | |
| CN1631430A (en) | Chinese medicinal ointment for treating bone diseases | |
| CN1872322A (en) | Medicinal powder for external application of treating rheumatism and spur | |
| CN1055242C (en) | Chinese medicine for curing aseptic necrosis of head of femur | |
| CN1943691A (en) | A Chinese traditional medicinal composition for treatment of osteoporosis and its preparation method | |
| CN1216617C (en) | Medicine for curing aseptic necrosis of head of femur | |
| CN1112191C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process | |
| CN100345560C (en) | Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method | |
| CN1055002C (en) | External-use cream for treatment of breast cancer | |
| CN1279958A (en) | Medicine for curing osteomyelitis and its preparing method | |
| CN1055398C (en) | Medicament for treatment of hyerosteogeny and its prepn. | |
| CN1262110A (en) | Medicine for treating pain of lumbus, leg, neck and shoulder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |